【my colleague found out about my kink manga】Laverne Cox Recalls 'Trauma' of Watching Loved Ones Die of HIV/AIDS and Wondering, 'Am I Next?'
This my colleague found out about my kink mangaWorld AIDS Day, red is the new black for
Laverne Cox
.
Reflecting on the
HIV/AIDS
epidemic, the
Orange Is the New Black
actress, 47, tells PEOPLE she thinks it is “insane” that AIDS-related illnesses are still killing hundreds of thousands of people worldwide each year, despite being preventable. That’s why she’s teamed up with
Band-Aid and RED
to fight for the cause.
“It’s intense that in 2019, AIDS is still an issue in a lot of parts of the world, that we have new transmissions every year,” Cox tells PEOPLE. “It’s insane to me when we can prevent it.”
The issue is personal for Cox, who, while HIV-negative, says the disease has been a reality for her throughout her life. When Cox was a child — and medications that now help people with HIV live longer did not yet exist — she saw two of her mother’s Black gay friends become HIV-positive and die.
She experienced loss again when a close friend she’d met while working at a New York City coffee shop became HIV-positive, and “deteriorate[d] mentally and physically” before her eyes prior to dying — something she says was “insanely traumatizing.”
Laverne Cox
“I know so many people who are living with HIV/AIDS and unfortunately far too many people who we’ve lost to the disease,” she says. “And there’s still a really crazy stigma around HIV/AIDS.”
That stigma and subsequent fear hasn’t subsided for Cox, who is also a prominent transgender activist.
RELATED:
HIV-Prevention Drugs Will Soon Be Available Without a Prescription at California Pharmacies
“I think people of a certain age have this trauma of like, watching people we know and love die and then the trauma of that, and the trauma of like, ‘Am I next?’ ” she says.
RELATED VIDEO: Pedro Zamora’s Real World Costars Remember AIDS Activist 25 Years After His Death
With that in mind, Cox boarded Band-Aid’s campaign in collaboration with RED, which is selling red bandages and donating 20 cents from each purchase to the “U.S. Fund for the Global Fund to support and fund Global Fund programs for the prevention and treatment of HIV/AIDS in sub-Saharan Africa,” according to the
campaign’s website
. That 20 cents will cover the cost of one day’s worth of antiretroviral medication for someone in the region.
RELATED:
Queer Eye’s Jonathan Van Ness Recalls the Day He Was Diagnosed HIV-Positive After Fainting
“What is so beautiful about what Johnson & Johnson and RED and Band-Aid are doing is that so much of this work is about educating people, providing medication, [but] then they’re also working to find a cure,” Cox explains. “These things have to go hand in hand if we really want to do the work of fighting HIV/AIDS globally.”
Johnson & Johnson announced in July that it’ll
launch the Mosaico trial
, the “second efficacy study to test Janssen [Pharmaceutical Company]’s mosaic-based vaccine concept, which is designed with the goal of protecting against a wide range of HIV-1 strains” responsible for HIV/AIDS.
Laverne Cox | Michael Simon/startraksphoto
The trial will focus on gay men and transgender people across North America, South America and Europe, with initial results expected in 2023.
Though Cox is openly HIV-negative, she tells PEOPLE it’s still necessary to discuss your status as a means of alleviating the stigma that surrounds the topic.
“I think so often in my experience as a Black trans woman, so often it’s assumed that I’m HIV-positive,” she says. “Like when someone knows I’m trans, the conversation around HIV/AIDS comes up in a way when they don’t know I’m trans, it doesn’t come up. Again, it’s these layers of stigma, and these are things we internalize.”
She continues, “We have to talk about stigma and shame directly to really have people understand that it’s something that we have to actively fight against.”
View comments
(责任编辑:Exploration)
- Loop Industries Reports Fourth Quarter Consolidated Financial Results of Fiscal 2020 and Provides Updates on Business Developments
- Key Things To Consider Before Buying Canaccord Genuity Group Inc. (TSE:CF) For Its Dividend
- Wall Street dives 4% as virus pandemic fears intensify
- Eversource (ES) Q3 Earnings Lag, Revenues Beat Estimates
- Coronavirus fears spark 'panic buying' of toilet paper, water, hand sanitizer. Here's why we all need to calm down
- ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against GFL Environmental Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
- Fiat Chrysler postpones shareholders' meeting and resolution on dividend to late June
- S.Korea's Moon tells Trump he would accept invitation to G7 summit
- Tap These 5 Bargain Stocks With Enticing EV/EBITDA Ratios
- Alm. Brand – Report on trading in Alm. Brand A/S shares by executives and their related parties
- UPDATE 1-MSCI to quadruple weighting of China A-shares in its global benchmarks
- What Is Berry's (NASDAQ:BRY) P/E Ratio After Its Share Price Tanked?
- What Can We Learn About FRP Holdings' (NASDAQ:FRPH) CEO Compensation?
- Video Meetings Can Be Superior Meetings
- Blockchain Could Make Dismantling Nuclear Warheads More Secure: UK Report
- SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, WFC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mesa Air Group, Inc. - MESA
- One Spark Networks SE (NYSEMKT:LOV) Broker Analyst Just Cut Their Revenue Numbers By 15%
- Sanofi to Withdraw Zantac After FDA Warns of Carcinogens
- The Best Places in Every State To Live on a Fixed Income